Author name: Yali Friedman

Canola Case Tests GMO Patent The future of genetically modified crops in North America is in the hands of a […]

Food Biotech Is Risky Business The genetically modified food industry has battled opposition from consumer and environmental groups to get

NBI On Drugs You won’t recognize the Nasdaq Biotechnology Index (NBI) the next time you see it. It’s undergone a

Glowing red GM fish to sell in US A tropical fish that fluoresces bright red is set to become the

Slowdown casts doubt on biotech offerings After a two-year capital drought, seven biotechnology and life sciences companies made initial public

Machine Could Sequence Human Genome in a Year A new gene-reading machine is so much faster than existing technology that

Biotech Raises More Cash in 2003 But Europe Weak The global biotechnology industry raised more money by the end of

Is That Daylight for ImClone? The beleaguered drugmaker finally gets some good news with Swiss approval of its cancer-fighting drug

Over the Rainbow Yet? Consolidation slows, valuations grow, and now hope for some IPOs

Ultimate Analysis With the necessary tools at hand, the race is on to build � and market � the first